SeaSpine 2017 revenue hits nearly $132M — 14 insights

Written by Megan Wood | February 28, 2018 | Print  |

SeaSpine reported its fourth quarter and full-year 2017 financial results.

Here are eight takeaways from the company's fourth quarter.


1. The company saw revenue of $34 million, reflecting a 4.5 percent year-over-year increase.


2. In the U.S., SeaSpine reported revenue of $31.2 million, a 4.8 percent year-over-year jump.


3. Orthobiologics revenue reached $18.1 million, an 8.8 percent year-over-year boost.


4. SeaSpine reported spinal implants revenue reached $15.9 million, which didn't register a significant change year over year.


5. The company saw $2.8 million in international revenue, which is a 1 percent year-over-year increase.


6. The company's gross margin was 63.3 percent, compared to 58.6 percent in the fourth quarter of 2016.


7. SeaSpine reported net loss of $7.5 million, compared to $9.8 million in the same period the year prior.


8. The company had $10.8 million in cash and cash equivalents on Dec. 31, 2017.


The following reflects the company's full-year 2017 financial results.


9. Full-year revenue reached $131.8 million, a 2.3 percent jump over 2016.


10. U.S. revenue hit $118.4 million, a 1.4 percent boost compared to 2016.


11. The orthobiologics revenue reached $69.1 million, a 4.4 percent jump from the year prior.


12. Spinal implant revenue totaled $62.7 million, a stagnant result compared to the year prior.


13. SeaSpine's gross margin was 60.7 percent in 2017.


14. The company had a net loss of $32.1 million, compared to $43.2 million in 2016.


SeaSpine anticipates full-year 2018 revenue to land between $135 million and $139 million.

More articles on devices:
Wright Medical reports $217.6M in Q4 sales: 6 takeaways
DePuy Synthes, Stryker, NuVasive & more: 12 device company notes
Ortho Sales Partners forming orthopedics and spine divisions, announces two executive additions: 4 things to know

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months